Plunkett Research Online: Cassava Sciences Inc

CASSAVA SCIENCES INC (SAVA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The firm specializes in developing new product candidates and guiding them through various regulatory and development pathways in preparation for their potential commercialization. Cassava’s research and .....



Cassava Sciences Inc
Ticker: SAVA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 512 501-2444
Fax: 650 624-8222
Address: 7801 N. Capital of Texas Highway
Suite 260
Austin, TX 78731 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Opioids
Neurodegenerative Diseases
Drug Development
ContactsDescription

Remi BarbierCEO/Chairman of the Board/Director/Founder/President/Secretary
Eric SchoenCFO
See More
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The firm specializes in developing new product candidates and guiding them through various regulatory and development pathways in preparation for their potential commercialization. Cassava’s research and .....See More See More

Auditor: EY
Legal Advisor: Wilson, Sonsini, Goodrich & Rosati
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
PTI-125
SavaDx
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: